IHAM
EXAS

Integral Health Asset Management’s Exact Sciences EXAS Stock Holding History

Integral Health Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-150,000
Closed -$10.4M – 87
2024
Q1 		$10.4M Buy
+150,000
New +$9.49M 0.96% 41

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Integral Health Asset Management's EXAS Position: Q4 2025 in Review

Integral Health Asset Management sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 200,000 shares — an estimated $10.9M sold.

Integral Health Asset Management first reported a position in EXAS in Q1 2020 and held it in 10 quarters. The position peaked at $13.6M in Q4 2022. 710 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Integral Health Asset Management reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Integral Health Asset Management sold 200,000 Exact Sciences shares in Q4 2025, an estimated $10.9M.
  • Integral Health Asset Management first reported a position in Exact Sciences in Q1 2020 and held it in 10 quarters.
  • Integral Health Asset Management's Exact Sciences position peaked at $13.6M in Q4 2022.
  • 710 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Integral Health Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.